Your session is about to expire
← Back to Search
Immunocal for Mild Cognitive Impairment
Study Summary
This trial is investigating whether an experimental drug can prevent or slow the progression of Alzheimer's disease or mild cognitive impairment.
- Mild Cognitive Impairment
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking other experimental medications or certain medications for mental health.You have taken N-acetylcysteine, α-lipoic acid supplements, other whey protein supplements, or Vitamin C within 2 months before starting the study and during the entire 6-month study period.You have allergies or intolerance to milk proteins.You have a serious illness like cancer, rheumatoid arthritis, Parkinson's disease, multiple sclerosis, major depression, or schizophrenia.You have a medical history that requires you to follow a diet low in protein.You have been diagnosed with mild cognitive impairment (MCI).
- Group 1: Interventional
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being taken into consideration for this research project?
"Indeed, the information on clinicaltrials.gov affirms that this research is actively seeking participants and applications have been open since February 5th 2018. The study requires 25 individuals to be enrolled from a single site and was last revised on February 9th 2021."
Does this experiment allow for participation from those above the legal age of majority?
"This research requires potential participants to be aged 55 or over but no more than 85 years old."
Is there currently a recruitment process underway for this research endeavor?
"Affirmative, information published on clinicaltrials.gov reveals that this experiment is proactively searching for participants. This research was posted in February 5th 2018 and revised lastly on February 9th 2021. 25 patients must be recruited from 1 site to complete the trial."
Is there a way to become involved in this research initiative?
"This study is seeking 25 qualified individuals, aged from 55 to 85 years old, who have experienced cognitive deterioration."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger